Cadent Therapeutics Acquired by Novartis for Up to $770 Million By Aydin H. Harston on December 18, 2020 Posted in Trends & Analysis Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the… Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million